Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

99 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 11c-acetate Acetate - - - 3件: 13, 86, 88 💬
2 [18f]fluoro-2-deoxy-2-d-glucose D-glucose 1件: D00009 💬 - - 2件: 86, 88 💬
3 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
4 Act-064992 - - - - 5件: 51, 85, 86, 88, 210 💬
5 Act-293987 - - - - 3件: 51, 86, 88 💬
6 Adempas - - - - 5件: 51, 86, 88, 225, 299 💬
7 Adempas (riociguat, bay63-2521) Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 2件: 86, 88 💬
8 Adempas® - - - - 2件: 86, 88 💬
9 Ambrisentan Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 7件: 51, 84, 85, 86, 88, 210, 211 💬
10 Ambrisentan 5 mg Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 88 💬
11 Ammonia Ammonia 1件: D02916 💬 - - 4件:  6 , 17, 86, 88 💬
12 Atorvastatin Atorvastatin 3件: D00258, D00887, D07474 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
13 Barnascan - - - - 1件: 88 💬
14 Bay 63-2521 - - - - 2件: 86, 88 💬
15 Bay 63-2521 coated tablets 0.5 mg - - - - 2件: 86, 88 💬
16 Bay 63-2521 coated tablets 1 mg - - - - 2件: 86, 88 💬
17 Bay 63-2521 coated tablets 1.5 mg - - - - 2件: 86, 88 💬
18 Bay 63-2521 coated tablets 2 mg - - - - 2件: 86, 88 💬
19 Bay 63-2521 coated tablets 2.5 mg - - - - 2件: 86, 88 💬
20 Bay 63-2521 ir coated tablet 1.0 mg - - - - 1件: 88 💬
21 Bay 63-2521 ir coated tablet 1.5 mg - - - - 1件: 88 💬
22 Bay 63-2521 ir coated tablet 2.0 mg - - - - 1件: 88 💬
23 Bay 63-2521 ir coated tablet 2.5 mg - - - - 1件: 88 💬
24 Bay 63-2521 ir tablet 0.5 mg - - - - 1件: 88 💬
25 Bay 63-2521 ir tablet 1.0 mg - - - - 1件: 88 💬
26 Bay 63-2521 ir tablet 1.5 mg - - - - 1件: 88 💬
27 Bay 63-2521 ir tablet 2.0 mg - - - - 1件: 88 💬
28 Bay 63-2521 ir tablet 2.5 mg - - - - 1件: 88 💬
29 Bay 63-2521 tablets 0.5 mg - - - - 2件: 86, 88 💬
30 Bay 63-2521 tablets 1 mg - - - - 2件: 86, 88 💬
31 Bay 63-2521 tablets 1.5 mg - - - - 2件: 86, 88 💬
32 Bay 63-2521 tablets 2 mg - - - - 2件: 86, 88 💬
33 Bay 63-2521 tablets 2.5 mg - - - - 2件: 86, 88 💬
34 Bay1237592 - - - - 2件: 86, 88 💬
35 Behavioral: respiratory and exercise therapy - - - - 1件: 88 💬
36 Behavioral: respiratory and exercise therapy with supplemental oxygen Oxygen 1件: D00003 💬 - - 1件: 88 💬
37 Bosentan Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
38 Bosentan monohydrate Bosentan 2件: D01227, D07538 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 4件: 51, 84, 86, 88 💬
39 Bpa - - - - 1件: 88 💬
40 Cysteine Cysteine 2件: D00026, D02326 💬 - - 11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
41 D-glucose D-glucose 1件: D00009 💬 - - 3件: 49, 86, 88 💬
42 Diagnostic test: endogenous thrombin potential Thrombin 1件: D00090 💬 - - 2件: 86, 88 💬
43 Diagnostic test: light transmission aggregometry - - - - 2件: 86, 88 💬
44 Diagnostic test: platelet function analyzer-100 - - - - 2件: 86, 88 💬
45 Diagnostic test: rotational thromboelastometry - - - - 2件: 86, 88 💬
46 Edoxaban Edoxaban 2件: D09546, D09710 💬 1件: F10 💬 1件: Complement and coagulation cascades 2件: 46, 88 💬
47 Fludeoxyglucose Fludeoxyglucose 1件: D01843 💬 - - 4件: 34, 84, 85, 88 💬
48 Glucose Dextrose, unspecified form - - - 15件:  2 ,  6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
49 Gsk1325760 - - - - 2件: 86, 88 💬
50 Imatinib Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
51 Imatinib mesilate Imatinib 2件: D01441, D08066 💬 3件: ABL1, KIT, PDGFRA 💬 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 3件: 13, 86, 88 💬
52 Iodine Iodine 1件: D00108 💬 - - 2件: 46, 88 💬
53 Jnj-67896062 / act-064992 - - - - 2件: 86, 88 💬
54 Macitentan Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件: 51, 85, 86, 88, 210 💬
55 Macitentan 10 mg Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 86, 88 💬
56 Macitentan tablets Macitentan 1件: D10135 💬 2件: EDNRA, EDNRB 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 86, 88 💬
57 Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb - - - - 2件: 86, 88 💬
58 Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth - - - - 2件: 86, 88 💬
59 Multihance - - - - 2件: 86, 88 💬
60 N-acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 7件: 13, 19, 34, 85, 88, 296, 310 💬
61 Ns-304 - - - - 3件: 70, 86, 88 💬
62 Ns-304 placebo - - - - 2件: 70, 88 💬
63 Opsumit - - - - 3件: 86, 88, 210 💬
64 Opsumit® - - - - 3件: 86, 88, 210 💬
65 Oxygen Oxygen 1件: D00003 💬 - - 18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
66 Oxygen, liquid Oxygen 1件: D00003 💬 - - 2件: 86, 88 💬
67 Ph-combination therapy - - - - 2件: 86, 88 💬
68 Ph-monotherapy - - - - 2件: 86, 88 💬
69 Placebo - - - - 26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
70 Procedure: ballon pulmonary angioplasty - - - - 1件: 88 💬
71 Procedure: balloon pulmonary angioplasty (bpa) - - - - 1件: 88 💬
72 Procedure: long term oxygen therapy Oxygen 1件: D00003 💬 - - 1件: 88 💬
73 Procedure: no gas - - - - 2件: 86, 88 💬
74 Procedure: pulmonary endarterectomy - - - - 1件: 88 💬
75 Procedure: pulmonary endarteriectomy - - - - 1件: 88 💬
76 Procedure: supplemental oxygen via a mask Oxygen 1件: D00003 💬 - - 1件: 88 💬
77 Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3) Ammonia 1件: D02916 💬 - - 1件: 88 💬
78 Radiation: computed tomography lung subtraction iodine mapping Iodine 1件: D00108 💬 - - 1件: 88 💬
79 Remodulin - - - - 2件: 86, 88 💬
80 Remodulin (r) - - - - 1件: 88 💬
81 Remodulin 10mg/ml 20ml - - - - 1件: 88 💬
82 Remodulin 1mg/ml 20ml - - - - 1件: 88 💬
83 Remodulin 2.5mg/ml 20ml - - - - 1件: 88 💬
84 Remodulin 5mg/ml 20ml - - - - 1件: 88 💬
85 Riociguat Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 6件: 51, 84, 86, 88, 225, 299 💬
86 Riociguat (adempas, bay63-2521) Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 4件: 51, 86, 88, 299 💬
87 Riociguat oral tablet Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 88 💬
88 Ro 47-0203 - - - - 4件: 51, 85, 86, 88 💬
89 Sauerstoff - - - - 2件: 86, 88 💬
90 Selexipag Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 5件: 51, 70, 84, 86, 88 💬
91 Thrombin Thrombin 1件: D00090 💬 - - 2件: 86, 88 💬
92 Tracleer - - - - 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
93 Tracleer 125mg 56cpr riv. - - - - 1件: 88 💬
94 Tracleer*56cpr riv 125mg - - - - 3件: 51, 86, 88 💬
95 Treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 6件: 51, 84, 85, 86, 88, 210 💬
96 Treprostinil sodium Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 3件: 51, 86, 88 💬
97 Uptravi - - - - 3件: 84, 86, 88 💬
98 Volibris - - - - 4件: 51, 85, 86, 88 💬
99 Warfarin Warfarin 3件: D00564, D01280, D08682 💬 2件: NQO1, VKORC1 💬 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬

先頭へ